![]() |
Volumn 9, Issue 3, 1999, Pages 137-144
|
Issues in cyclosporine drug substitution: Implications for patient management
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CALCINEURIN;
CYCLOSPORIN A;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE SODIUM SUCCINATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
UNCLASSIFIED DRUG;
ARTICLE;
BIOEQUIVALENCE;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
PATIENT CARE;
TREATMENT OUTCOME;
|
EID: 0032735465
PISSN: 09059199
EISSN: None
Source Type: Journal
DOI: 10.7182/prtr.1.9.3.37u315q858u8307x Document Type: Article |
Times cited : (14)
|
References (33)
|